As a preclinical practice, the usage of USP7 inhibitors combined with bortezomib triggers synergistic antitumor activity.479 Additionally, in PI-resistant MM, the E1 Ub-activating enzyme inhibitor TAK-243 can also block myeloma cell proliferation and induce apoptosis.480. The gene discussed is USP7; the disease is Miyoshi myopathy.